Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Other antiarrhythmic agents]

T Sato1

  • 12nd Department of Internal Medicine, Teikyo University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

This paper reviews recent advances in Digitalis for atrial fibrillation, ATP for paroxysmal supraventricular tachycardia, and enalapril for reducing sudden cardiac death in heart failure patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevation of hepatic levels of metallothionein and zinc in mice bearing experimental tumors.

Biochemical and biophysical research communications·1992
Same author

Relationship between inhibitor of extrathyroidal 5'-deiodinase activity and serum free fatty acid in children with nonthyroidal illness and acute ketosis.

Endocrinologia japonica·1992
Same author

Preferential activation of phospholipase A2 by low concentrations of phosphatidic acid with long-chain fatty acids in rabbit platelets.

Journal of biochemistry·1992
Same author

Innervation of an aberrant digastric muscle in the posterior thigh: stratified relationships between branches of the inferior gluteal nerve.

Journal of anatomy·1992
Same author

A simple stimulator for periodontal mechanoreceptors in human subjects.

Journal de biologie buccale·1992
Same author

Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.

Cardiovascular research·1992

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Digitalis effectively manages chronic atrial fibrillation (AF) ventricular rates.
  • Atrial flutter and paroxysmal supraventricular tachycardia (PSVT) also benefit from Digitalis.
  • Adenosine triphosphate (ATP) is a primary choice for rapid PSVT termination.

Purpose of the Study:

  • To describe recent advancements in the therapeutic applications of Digitalis, ATP, and enalapril.
  • To highlight the role of these drugs in managing cardiac arrhythmias and heart failure.

Main Methods:

  • Review of recent literature and clinical findings regarding Digitalis, ATP, and enalapril.
  • Analysis of data from studies like V-HeFT II concerning enalapril's impact on mortality.

Main Results:

Related Experiment Videos

  • Digitalis is established for controlling ventricular rates in chronic AF, atrial flutter, and PSVT.
  • ATP is a first-line treatment for the acute termination of PSVT.
  • Enalapril demonstrated reduced mortality in V-HeFT II, likely by decreasing ventricular arrhythmias and increasing cardiac refractoriness.

Conclusions:

  • Recent research supports the continued utility of Digitalis, ATP, and enalapril in cardiovascular medicine.
  • These drugs offer distinct yet vital roles in managing arrhythmias and improving outcomes in heart failure patients.